Big Pharma’s Criminal / Civil Settlements
Two major cases of medical fraud have undermined patient safety and the integrity of the medico-scientific literature: But how each specialty responded is a study in contrast.
Access the case online here. Download the PDF here. We recommend that you also read the “AHRP Amicus Brief” Access the suggested reading at this link. GRIMES v. KENNEDY KRIEGER INSTITUTE INC (2001) Court of Appeals of Maryland Ericka GRIMES v. KENNEDY KRIEGER INSTITUTE, INC. Myron Higgins, a…
A battle is in full swing between scientists demanding access to clinical trial data from published reports; journal gatekeepers protect the interests of sponsors — commercial companies, academic institutions and government agencies. In numerous legal procedures, the claimed clinical trial results in published scientific reports have been shown to be…
AHRP PROPOSAL:
Any FDA-approved drug, whose manufacturer has been found by a court of law or the Department of Justice–to have illegally marketed the drug by concealing risks or incidence of adverse effects, or making unsupported claims of clinical benefit–should be denied coverage by taxpayer funded insurance programs–including Medicaid, Medicare, VeteranstAffairs.
100 Amgen scientists were astonished to find that they were able to replicate the results of only 6 of 53 widely cited landmark cancer research papers.
"Unless we put medical freedom into The Constitution, the time will come when medicine will organize into an undercover dictatorship." Dr. Benjamin Rush, a signatory to the Declaration of Independence.